<DOC>
	<DOCNO>NCT01715272</DOCNO>
	<brief_summary>This study design assess difference performance new enema ( TF037 ) Fleet enema distal bowel cleansing .</brief_summary>
	<brief_title>A Clinical Investigation Demonstrate Performance New Enema ( TF037 ) Distal Bowel Cleansing Compared With Fleet Enema</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject [ determined medical history , physical examination , laboratory test value , vital sign 12lead electrocardiogram ( ECGs ) screen ] age 18 60 year . Nonsmokers 3 month enema administration duration clinical investigation . Body mass index ( BMI ) ≥ 18 ≤ 35 kg/m2 . Must voluntarily provide write informed consent participate clinical investigation . Must understand purpose risk clinical investigation agree follow restriction schedule procedure define clinical investigation plan , confirm informed consent process . Female subject must postmenopausal ( least one year confirm serum follicle stimulate hormone ( FSH ) test screening ) , surgically sterile , practise true sexual abstinence must use effective method contraception . Female subject childbearing potential must negative serum pregnancy test screen negative urine pregnancy test checkin period . The subject 's primary care physician must confirm nothing medical history would preclude enrolment clinical investigation . Must willing consent data enter The Over Volunteering Prevention System ( TOPS ) . Subjects history presence significant cardiovascular disease , pulmonary , hepatic , gallbladder biliary tract , renal , haematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic psychiatric disease . Subjects history presence organic functional gastrointestinal condition ( e.g . chronic constipation , irritable bowel syndrome , inflammatory bowel disease ) . Subjects clinically relevant history presence abnormal gastrointestinal motility . Subjects significant history hereditary bowel disorder . Subjects abnormal finding digital rectal examination perform screen . Use laxatives motility alter drug 3 month precede enema administration . Use prescription overthecounter medication ( include vitamin , herbal mineral supplement ) within 14 day prior enema administration ( within 5 half life longer ) , exception Investigatorapproved hormonal contraceptive , hormone replacement therapy ( HRT ) occasional paracetamol , aspirin ibuprofen . Participation clinical drug study 30 day precede enema administration clinical investigation . Donation blood blood product within 30 day prior enema administration clinical investigation , except require clinical investigation Pregnant lactating female . Any clinically significant illness within 28 day prior enema administration . History presence significant drug allergy , know allergy contraindication trisodium citrate , Fleet® enema midazolam . Laboratory value screen deem clinically significant , unless agree advance Sponsor 's Medical Representative Principal Investigator . Positive human immunodeficiency virus ( HIV ) , hepatitis B hepatitis C. Current history drug alcohol abuse within 12 month prior enema administration , positive drug abuse test screening checkin . Consumption alcoholic beverage within 24 hour checkinor confinement . Subjects , opinion Investigator , unsuitable participation clinical investigation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>